Wyoming lawkmaker pushes for reform, Mississippi Governor bans certain over-the-counter drugs

NewsGuard 100/100 Score
Associated Press/CNBC: "A veteran Wyoming state senator for the third time is pushing a bill he says would offer health insurance to people who couldn't afford it on the open market and also serve as an example to the rest of the nation of how to tackle rising health care costs. Sen. Charles Scott, R-Casper, has proposed a pilot program that calls for allowing 500 participants to enroll in Medicaid beginning in July. It would be limited to people whose family income is below 250 percent of the federal poverty level — $55,125 for a family of four. Enrollment could rise to 3,000 participants by 2014. ... It would establish personal health accounts for each participant in which the state would match participant contributions. Participants could use the money in their accounts only to pay for health care and health insurance. They would retain any balance in their accounts when they left the program"  (2/11).

Pharmaceutical Business Review: Mississippi Gov. Haley Barbour signed a bill that restricts over-the-counter sales of drugs containing pseudoephedrine, an ingredient used by drug abusers to manufacture methamphetamine. Consumers will need a doctor's prescription and identification before purchasing such medicines. "Methamphetamine (meth) has high potential for abuse, activating the physiological reward system by increasing levels of dopamine and norepinephrine in the brain. The move is intended to reduce drug abuse due to these OTC drugs. The bill received good response in the legislature and was approved within a week. It will be effective from July 1, 2010" (2/12). 

The Jackson Clarion Ledger: "Supporters say the measure, which passed the House and Senate in recent weeks, will deter meth production. ... Mississippi is only the second state in the nation to require a prescription for pseudoephedrine. A similar law in Oregon went into effect about three years ago" (Crisp, 2/11).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show